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bstract
ntroduction:  The safety of health care is increasingly prominent concern of the public, applying to complementary and alternative medicine
CAM) as well as conventional treatment. In 2009, a group of academic and clinical CAM researchers held a workshop to discuss the constraints
nd priorities of research into CAM safety. This group here report their discussions, and offer collaboration with practitioners internationally with
he aim of improving patient safety for CAM practices and products.
iscussion:  Research into the safety of healthcare presents challenges, including definitions of terms where a recent WHO initiative is significant.
articular problems that must be addressed include: the apparently low incidence of harmful incidents; the limited regulatory setting for CAM
ractice including the omission of CAM interventions from most mainstream adverse event reporting schemes; the widespread perception of CAM
s natural and safe; the complexity of CAM therapies; interactions between CAM and conventional care; professional complacency; and the special
hallenges unique to specific CAM therapies such as the concept of a ‘healing crisis’. The researchers reached a consensus that the first priority
or CAM safety research is active surveillance, or the measurement of actual harm from CAM. The second priority is research into beliefs and
ttitudes of practitioners, public and professional organisations, and what influences those attitudes; the final research area covers the procedures
sed to ensure safe practice, and their effectiveness.
onclusions:  International collaboration between experts in the field, including practitioners and researchers, may be the best way to achieve the
equired levels of expertise.
This article belongs to the Special Issue: Ensuring and Improving Patient
 2013 The Authors. Published by Elsevier GmbH. All rights reserved.
eywords: Safety; Epidemiological monitoring; Complementary therapies; Adverse
 This is an open-access article distributed under the terms of the Creative
ommons Attribution-NonCommercial-ShareAlike License, which permits
on-commercial use, distribution, and reproduction in any medium, provided
he original author and source are credited.
 This article belongs to the Special Issue: Ensuring and Improving Patients’
afety in Integrative Health Care.
∗ Corresponding author. Tel.: +44 01752 764448.
E-mail addresses: Adrian.white@pms.ac.uk (A. White),
eather.boon@utoronto.ca (H. Boon), terje.alrak@uit.no (T. Alraek),
l3@soton.ac.uk (G. Lewith), Liujp@bucm.edu.cn (J.-P. Liu),
rne.johan.norheim@hlkbb.no (A.-J. Norheim), aslak.steinsbekk@ntnu.no
I
y
c
a
d
(
v
876-3820/$ – see front matter © 2013 The Authors. Published by Elsevier GmbH. A
ttp://dx.doi.org/10.1016/j.eujim.2013.09.006s’ Safety in Integrative Health Care.
 events; CAM, adverse effects; Safety management
ntroduction
The central aim of health care is to benefit its recipients;
et widespread experience has shown that healthcare itself
auses harm that is a major cause of worldwide morbidity
nd mortality [1]. The World Health Organisation (WHO)
esignated safety of health care as a global priority in 2002,
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Box  1.  WHO  Patient  Safety  Research:  research
sequence
Measuring  harm.
Understanding  the  causes.
Developing  solutions.
Learning  from  implementation.
Evaluating  impact.
Translating  improvements  into  policy  and
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Box  2.  Preferred  terms  and  deﬁnitions:  WHO
ICPS [6]
Safety:  the  reduction  of  risk  of  unnecessary1harm
to an  acceptable  minimum  (note:  some  forms
of harm  are  necessary,  such  as  an  incision  in
surgery).
Event: something  that  happens  to  or  involves  a
patient.
Incident  (in  full,  Patient  safety  incident):  an  event
or circumstance  which  could  have  resulted,  or  did
result,  in  unnecessary  harm  to  a  patient.
Harmful  incident  (formerly  adverse  event):  an
incident  that  resulted  in  harm  to  a  patient.
Side effect:  a  known  effect,  other  than  that  pri-
marily intended,  related  to  the  pharmacological
properties  of  a  medication.
Adverse  reaction: unexpected  harm  resulting
from a  justiﬁed  action  where  the  correct  process
was followed  for  the  context  in  which  the  event
occurred.
Incident type:  a  descriptive  term  for  a  category
made up  of  incidents  of  a  common  nature,  groups
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e
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The study of the harmful incidents associated with CAM
does not necessarily require a different research approach frompractice.
nd established a Patient Safety initiative which published a
onceptual framework [2] describing the steps necessary for
mproving safety in practice (Box 1).
Complementary and alternative medicine (CAM) has been
efined as a group of diverse medical and health care systems,
ractices, and products that are not generally considered part of
onventional medicine (http://nccam.nih.gov/health/whatiscam
ccessed 21 November 2012). Although debate rages about the
linical effect of CAM interventions, surveys from many parts of
he world have consistently documented that a high proportion of
he population uses CAM [3]. CAM thus forms a common com-
onent of health care choice globally, and must meet patients’
emands for effectiveness and safety.
Recently, a report of a workshop of UK practitioners on
AM safety was published, focussing on building the evidence
ase and exploring research priorities [4]. The report describes
ractitioner competencies and identifies a range of methods for
ollecting safety data, citing three examples of surveillance.
he report specifically invites comments from practitioners and
esearchers in other countries.
In 2009, an international workshop of academic and clinical
esearchers with a special interest in CAM safety was held in
romsø, Norway under the auspices of NAFKAM (National
esearch Centre in Complementary and Alternative Medicine).
iscussion focussed on priorities, methods and constraints of
esearch into CAM safety. The benefits that this type of group of
cademic researchers could offer to any collaboration include:
 range of experience in the field; theoretical understanding;
onsistency of terminology, definitions and research methods;
nd identification of methodology and constraints on research.
The first author drafted and circulated the workshop report,
hich was based on notes and flip-charts and evolved further
n response to the group’s comments. Discussion included the
onstraints to researching CAM safety, and the need to establish
esearch priorities. An email consensus was used for the latter.
he group considered it timely to report their conclusions on
oth constraints and research priorities in this special issue of
uJIM, aiming to promote a merger of the practical approaches
f practitioners with the theoretical and literature-based under-
inning and international dimension provided by academia.
eﬁnitions  of  terms
Any discussion of healthcare safety is complicated by incon-
istencies in terminology and definitions, as well as differences dbecause of  shared,  agreed  features.
n key concepts such as how to classify adverse events. For
xample, definitions produced in Australia, Canada and Europe
re not consistent. The World Alliance for Patient Safety, as
art of the WHO initiative on Patient Safety, reached a con-
ensus on a new International Classification of Patient Safety
ICPS) [5,6]. This classification includes a set of standardised
afety definitions that were intended to be clear and unequivocal
nd to reflect the colloquial use of terms, as well as being con-
istent with the WHO Family of International Classifications.
he advantage of such a universal system should be obvious in
elation to collecting, classifying and analysing safety data.
Some of the more relevant definitions are set out in Box 2. One
mportant change is the renaming of ‘adverse event’ to ‘harmful
ncident’, which is intended to avoid the common confusion
etween the terms ‘adverse event’ and ‘adverse reaction’.
The WHO have identified different forms of classification of
isk for different purposes, and the ICPS presented a classifica-
ion of 13 incident types [6], such as ‘clinical administration’,
clinical process’, and ‘behaviour’, that aims to be universally
pplicable. All incident types except one (‘oxygen/gas/vapour’)
eem potentially relevant to CAM.
The author group has agreed that this set of definitions is
elevant and applicable for use in research on CAM safety.
pecial  challenges  in  CAM  safety  research1 The word ‘unnecessary’ recognises that errors, violations, patient abuse and
eliberate unsafe acts occur in health care and are unnecessary acts [6].
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onventional health care; indeed it is important to apply the
nowledge and expertise already gained. But the research team
ust include people with specialist knowledge of CAM. The
axonomy for collecting reports on errors should be based on the-
retical error concepts and should include information on system
actors [7]. There are, however, special factors that might impede
 research project into CAM safety. These challenges, though
resented here primarily in relation to surveillance projects, also
aise secondary research questions of their own.
ow incidence  of  harmful  incidents
Serious CAM-related risks appear to be rare. To take
cupuncture as an example, several large, prospective surveys
ave established its safety in Japan [8], the UK [9,10] and
ermany [11,12]. The data from about 2.2 million treatment
essions suggest the maximum risk of serious harmful incident
s 1:76,000 patients treated [12]. Similarly, a prospective survey
f 50,276 cervical manipulations identified no serious harmful
ncidents [13]. These data suggest the risks of CAM could be
anked as ‘very low’, according to one classification [14]. In
articular, homeopathic products are highly diluted and appear
o present little risk [15]. Therefore large sample sizes, possi-
ly requiring international collaborations, are required if precise
nferences are to be made from surveillance studies.
ack of  regulatory  setting  of  CAM  practice
In many countries CAM practice is provided outside the
ational healthcare systems and practised by non-regulated per-
onnel. CAM may therefore not be monitored by the safety
echanisms and reporting systems incorporated into main-
tream regulatory and legislative frameworks. Even those CAM
ractices and products that are regulated rarely have adequate
ystems in place for reporting, assessing and acting on harmful
ncidents.
Where care overlaps or is shared, conventional health care
ractitioners often have little knowledge of CAM products or
herapies [16], and are often unaware that their patients are seek-
ng CAM providers or use their products [17]. Interactions with
rugs are thereby less likely to be identified and reported.
Even when national surveillance systems have the capacity
o collect information about CAM-related harmful incidents (as
s the case with many adverse drug reaction registries such as
he yellow card system in the UK [18]), few patients or practi-
ioners (CAM or conventional) appear aware of this [19]. This
onstitutes specific challenges for CAM in addition to the chal-
enges already inherent in the majority of established passive
urveillance systems for safety in conventional medicine.
The different forms of self-regulation and the lack of reg-
latory bodies or professional organizations for some CAM
ractices and products make it difficult to conceptualize who
ight undertake to systematically identify risk associated with
AM. Robust new surveillance systems will need to be devel-
ped, together with an exploration into how the concept of risk in
AM can be established in the professions in a way that enables
he full and accurate reporting of the harmful incidents.
a
s
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trative Medicine 6 (2014) 404–408
erceived  as safe  due  to  being  “natural”
The philosophy of CAM therapies generally emphasises their
ode of action in ‘mobilising self-healing’ which implies they
ust be perfectly safe. Up to 90% of patients regard CAM as safe
nd so often do not even consider the possibility that treatment
ay have side effects [20]. Patients might be less likely to report
armful incidents that may be associated with natural products
han with conventional pharmaceuticals, suggesting this may be
elated to preconceived ideas about the inherent safety of natural
roducts [21].
Homeopathic remedies are generally considered safe so
atients may increase the dose, risking overdose with non-
omeopathic ingredients, such as ‘non-active’ solvents, up to
oxic levels [22]. Furthermore, risk may arise from ‘mistaken
dentity’, where e.g. herbal and other medicines are described
s homeopathic to make them look safer [23]. Deliberate con-
amination during preparation constitutes another risk [24].
These factors makes it less likely that CAM-related harm-
ul incidents will be identified and reported, particularly via the
assive surveillance systems currently in place for conventional
reatments, which are themselves subject to serious underreport-
ng. These factors also raise research questions about how the
ublic can be educated to understand that CAM practices and
roducts may be associated with harmful events, without causing
nnecessary alarm.
omplex  interventions
For some CAM treatments it is often easy to identify the
omponent responsible for the harmful incident (for example,
he acupuncture needle), but a large proportion of CAM inter-
entions constitute complex treatments. Researchers need to
etermine whether they should pursue a search for a harm-
ul component or address safety at a systematic level. Little
xperience is available at the present time with regard to this
atter.
Medicinal products used in CAM such as plant extracts are
ikely to be pharmacologically complex and so have multiple
hysiological effects which may represent a beneficial synergy
r harmful interaction, depending on the specific context. This
roblem is exacerbated by the common practice of combining
any compounds in one product making it difficult to identify
otential harmful incidents or interactions with other products.
nteractions  with  conventional  medicine
The research situation becomes even more complicated when
aking into account that many patients using CAM simulta-
eously use conventional practices and drugs. Although there
s some high-quality research about herbal medicine-drug inter-
ctions, this research has mainly been carried out on single
tandardised herbal medicines. Broadening this field into inter-
ction in general creates many challenges [25].
Information given to patients by conventional or by CAM
ractitioners might adversely influence belief in or uptake of
he other type of therapy, including for example failure of CAM
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ractitioners to refer patients when more effective conventional
reatment is available for their condition [26].
omplacency
Discussion of safety can be interpreted by CAM practitioners
s confrontational and an insult to their professional integrity.
or example, a systematic review of reported harmful incidents
f acupuncture [27] first generated a defensive response before
rofessional acupuncturists came to consider safety as a legit-
mate topic of research, [28] and subsequently became active
esearch collaborators [29].
Complacency is a likely cause of under-reporting for all pas-
ive surveillance systems [21,30]. In conventional medicine,
stimates suggest that as few as 6% of all harmful incidents
re ever reported [31], but there is evidence that the problem
ay be even worse for CAM products [30].
A specific challenge will be to develop methods to circum-
ent the complacency present among some CAM traditions with
egard to potential harm of their treatments.
pecial  challenge:  ‘healing  crisis’
One risk-related issue that is relevant to the safety of
ome CAM therapies is the so-called healing crisis, also
nown as a ‘therapeutic aggravation’. This event is particu-
arly linked to homeopathy, but may be reported with other
AM therapies. It has been defined as: ‘Temporary worsening
f existing symptoms following the administration of correctly
hosen homeopathic prescription, which indicates a favourable
esponse to treatment’ [32].
CAM practitioners regard a healing crisis as a positive sign
hat predicts subsequent improvement in the condition as it is
een to be a sign that the body’s self healing potential has been
ctivated. There are only few examples of research into this
oncept [33], although the phenomena has been widely reported
or centuries [34].
The healing crisis meets the usual definition of a harmful
ncident (Box 2). Practitioners might argue that the healing cri-
is is a desired event and therefore not adverse, but until it has
een demonstrated that the healing crisis is an important com-
onent of treatment effectiveness, then we regard it as a harmful
vent. A similar example from conventional medicine would be
he fever and localised inflammation associated with immuniza-
ions: this may be evidence of an immunological response, but
s still harmful and patients must be informed about the risk. We
eed to understand the associated effectiveness, the frequency in
ifferent therapies and different cultures, the predictability, and
he relationship to different therapists, of the so called ‘healing
risis’.
riorities  for  researchThe NAFKAM workshop provided a forum for an initial shar-
ng of ideas and experiences, and subsequently attendees agreed
o conduct an email consensus (modified Delphi method) exer-
ise to establish research priorities. First, 14 potential research
r
f
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frative Medicine 6 (2014) 404–408 407
opics were identified by the lead author from notes and flip-
harts of the meeting combined with a survey of safety literature.
he topics related to five areas: practitioner training, pro-
essional regulation, public belief and attitudes, registry, and
urveillance. Each topic was then expressed in the form of one,
r sometimes two, generalised research aims (for example, the
opic of professional regulation naturally led to the research aim:
Review the operation of organisations responsible for oversee-
ng CAM safety’). In the first round, the seven participants were
sked to comment on the relevance of the topics and aims, and
o suggest revisions and improvements to the wording. Their
omments were summarised and presented back to participants
ith revised research aims, in a second round. Participants were
nvited to rate their top five priorities, in order. The resulting
esearch priorities, with mean scores of ratings, were as follows
1 is most important, 5 least important):
. Active surveillance projects including vulnerable patients
and concomitant use of conventional care; score 1.2.
. Attitude to safety among CAM practitioners (i.e. the extent
to which safety is integral to clinical practice); score 2.7.
. Influences on, and changes in, public and patient beliefs and
attitudes to CAM safety; score 3.5.
. Attitude to safety in CAM professional organisations (i.e. the
extent to which safety is considered integral in all thinking
and decisions); score 3.2.
. Procedures (and their effectiveness) that CAM professional
organisations use to ensure continued safe practice by their
members; score 4.2.
onclusion
In a period of increasing societal interest in safety of health
are, the CAM professions and individual practitioners have a
esponsibility to question and enhance the safety of their prod-
cts and practices. A number of challenges exist. To reduce the
isk, the harmful incidents associated with various CAM prod-
cts and practices should first be documented, particularly where
ata are sparse.
Research should also be undertaken into diminishing risk
here appropriate, especially how to enhance the safety cul-
ure among the stakeholders representing different products and
ractices. These projects need international collaboration to
evelop and provide specialised resources and avoid duplication,
nd to provide sufficiently large datasets in sufficient diversity
f practice to be meaningful.
More information is needed about the incidence of these
vents in different settings and population groups. The extensive
ange of harmful incidents potentially associated with CAM, as
ell as the range of activities that are described as CAM practice
long with the number of organisations involved in training
r overseeing practitioners constitute a significant problem for
esearch in this area. These issues need to be considered care-
ully to facilitate further understanding of the events as well as
he prospective design and evaluation of strategies to reduce the
uture risk.
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